Uric Acid Control in Advanced Chronic Kidney Disease in a Southeastern US Urban Cohort

被引:3
作者
Fueloep, Tibor
Koch, Christian A.
Norris, Lindsey T.
Rodriguez, Betzaida
Szarvas, Tibor
Lengvarszky, Zsolt
Csongradi, Eva
Dixit, Mehul P.
机构
[1] Ralph H Johnson VA Med Ctr, Med Serv, Charleston, SC USA
[2] Tech Univ Dresden, Dept Med 3, Dresden, Germany
[3] Univ Mississippi, Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Jackson, MS 39216 USA
[4] Univ Mississippi, Med Ctr, Dept Med, Div Nephrol, Jackson, MS 39216 USA
[5] Louisiana State Univ, Dept Math, Shreveport, LA 71105 USA
[6] Univ Debrecen, Fac Med, Dept Lab Med, Debrecen, Hungary
[7] Univ Mississippi, Med Ctr, Dept Pediat, Div Pediat Nephrol, Jackson, MS 39216 USA
关键词
allopurinol; body mass index; body weight serum bicarbonate; urine pH; URATE-LOWERING THERAPY; AFRICAN-AMERICANS; RENAL-FUNCTION; METABOLIC-ACIDOSIS; SLEEP-APNEA; ALLOPURINOL; HYPERURICEMIA; PROGRESSION; MANAGEMENT; RISK;
D O I
10.14423/SMJ.0000000000000862
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Uric acid (UA) control may be insufficient in chronic kidney disease (CKD) patients in the current era. It is unclear, however, whether this is the result of environmental effects, patient anthropometrics or insufficient dosing of medical therapy (allopurinol). Methods We have collected data on multiple clinical and laboratory parameters of 114 CKD clinic patients attending the nephrology clinic of the University of Mississippi Medical Center with an estimated glomerular filtration rate <45 mL min(-1)1.73 m(2). We assessed the correlates of UA levels and the allopurinol doses along with achieved serum UA and urine pH. Results The cohort consisted of middle-aged to elderly patients with a mean ( standard deviation) age of 62.1 (11.6) years; 45.6% were female, 68.4% were African American and 47.4% had a history of gout. The mean UA level was 7.7 (2.49) mg/dL (range 3.1-16), allopurinol dose was 192 (99) mg/day (range 50-450) and estimated glomerular filtration rate was 23.8 (11.3) mL min(-1)1.73 m(2). While the overall serum bicarbonate level was 25 (3.2) mEq/L, urine pH was <6 in 60.5% of the cohort. Significant univariate correlates of the administered doses of allopurinol were weight (r 0.317, P = 0.001), body mass index (BMI; r 0.313, P = 0.001), and female sex (r -0.198; P = 0.035). Achieved UA levels correlated directly with BMI (r 0.201, r = 0.036) but inversely with the allopurinol dose (r -0.196; P = 0.036). During logistic regression analysis with stepwise selection, only weight ( 0.313, P = 0.001) and sex ( -0.190, P = 0.039) proved to be predictive of the allopurinol dose; as for the achieved UA level, only BMI ( 0.271, P = 0.006) and the allopurinol dose ( -0.258; P = 0.009) had a significant effect. Conclusions In patients with advanced CKD, conventional dosing recommendations for allopurinol are unlikely to suffice in reaching target serum UA goals. In our cohort, larger-than-usual allopurinol doses were well tolerated.
引用
收藏
页码:549 / 555
页数:7
相关论文
共 48 条
  • [1] Persisting Hypocalcemia After Surgical Parathyroidectomy: The Differential Effectiveness of Calcium Citrate Versus Calcium Carbonate With Acid Suppression
    Afshan, Sabahat
    Musa, Abdeen R. Farah
    Echols, Vonda
    Lerant, Anna A.
    Fulop, Tibor
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2017, 353 (01) : 82 - 86
  • [2] The effects of allopurinol on metabolic acidosis and endothelial functions in chronic kidney disease patients
    Bayram, Dilara
    Sezer, M. Tugrul
    Inal, Salih
    Altuntas, Atila
    Kidir, Veysel
    Orhan, Hikmet
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2015, 19 (03) : 443 - 449
  • [3] Management of Chronic Kidney Disease: What is the Evidence?
    Brosnahan, Godela
    Fraer, Mony
    [J]. SOUTHERN MEDICAL JOURNAL, 2010, 103 (03) : 222 - 230
  • [4] Chao Jeannie, 2009, Curr Rheumatol Rep, V11, P135
  • [5] Current Concepts and Management Strategies in Chronic Kidney Disease-Mineral and Bone Disorder
    Chauhan, Veeraish
    Kelepouris, Ellie
    Chauhan, Nishtha
    Vaid, Megha
    [J]. SOUTHERN MEDICAL JOURNAL, 2012, 105 (09) : 479 - 485
  • [6] DailyMed, LAB ZYL ALL TABL
  • [7] Dalbeth N, 2006, J RHEUMATOL, V33, P1646
  • [8] Bicarbonate Supplementation Slows Progression of CKD and Improves Nutritional Status
    de Brito-Ashurst, Ione
    Varagunam, Mira
    Raftery, Martin J.
    Yaqoob, Muhammad M.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (09): : 2075 - 2084
  • [9] Desideri G, 2014, EUR REV MED PHARMACO, V18, P1295
  • [10] Hyperuricemia and chronic kidney disease: an enigma yet to be solved
    Dousdampanis, Periklis
    Trigka, Konstantina
    Musso, Carlos G.
    Fourtounas, Costas
    [J]. RENAL FAILURE, 2014, 36 (09) : 1351 - 1359